Comparison of Occlusive and Open Application in a Psoriasis Plaque Test Design, Exemplarily Using Investigations of Mapracorat 0.1% Ointment versus Vehicle and Reference Drugs-Reference-Cited by-同舟云学术

Comparison of Occlusive and Open Application in a Psoriasis Plaque Test Design, Exemplarily Using Investigations of Mapracorat 0.1% Ointment versus Vehicle and Reference Drugs

Published:2017 Issue:2 Volume:30 Page:102-114
ISSN:1660-5527
Container-title:Skin Pharmacology and Physiology
language:en
Short-container-title:Skin Pharmacol Physiol

Author:

Wigger-Alberti Walter,Williams Ragna,von Mackensen Yi-Ling,Hoffman-Wecker Maciej,Grossmann Ulrike,Staedtler Gerald,Nkulikiyinka Richard,Shakery Kaweh

Publisher

S. Karger AG

Subject

Dermatology,Pharmacology,Physiology,General Medicine

Reference25 articles.

1. Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb AB, Koo JY, Lebwohl M, Lim HW, Van Voorhees AS, Beutner KR, Bhushan R: Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol 2009;61:451-485.

2. Lande R, Botti E, Jandus C, Dojcinovic D, Fanelli G, Conrad C, Chamilos G, Feldmeyer L, Marinari B, Chon S, Vence L, Riccieri V, Guillaume P, Navarini AA, Romero P, Costanzo A, Piccolella E, Gilliet M, Frasca L: The anti-microbial peptide LL37 is a T-cell autoantigen in psoriasis. Nat Commun 2014;5:5621.

3. Arakawa A, Siewert K, Stöhr J, Besgen P, Kim SM, Rühl G, Nickel J, Vollmer S, Thomas P, Krebs S, Pinkert S, Spannagl M, Held K, Kammerbauer C, Besch R, Dornmair K, Prinz JC: Melanocyte antigen triggers autoimmunity in human psoriasis. J Exp Med 2015;212:2203-2212.

4. Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb A, Koo JY, Lebwohl M, Leonardi CL, Lim HW, Van Voorhees AS, Beutner KR, Ryan C, Bhushan R: Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. J Am Acad Dermatol 2011;65:137-174.

5. Rafael A, Torres T: Topical therapy for psoriasis: a promising future. Focus on JAK and phosphodiesterase-4 inhibitors. Eur J Dermatol 2016;26:3-8.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pressure and Skin: A Review of Disease Entities Driven or Influenced by Mechanical Pressure;American Journal of Clinical Dermatology;2023-12-30

2. A glucocorticoid-receptor agonist ameliorates bleomycin-induced alveolar simplification in newborn rats;Pediatric Research;2022-09-06

3. A selective glucocorticoid receptor modulator attenuates lung inflammation and improves alveolarization in a neonatal rat model of bronchopulmonary dysplasia;2021-04-28

4. Efficacy and safety of fixed‐dose combination calcipotriol/betamethasone dipropionate foam for the treatment of psoriasis;Journal of the European Academy of Dermatology and Venereology;2021-02

5. A phase I, randomized, double‐blind study to assess the safety, tolerability and efficacy of the topical RORC2 inverse agonist PF‐06763809 in participants with mild‐to‐moderate plaque psoriasis;Clinical and Experimental Dermatology;2020-09-14